Lung transplants in Spain: An update;Actualización del trasplante pulmonar en España

Archivos de Bronconeumologia

Volumn 41, Issue 8, 2005, Pages 457-467

  Borro, J M ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; REVIEW; SPAIN; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 25144523071     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077957     Document Type: Review

References (120)

1. Serrano Muñoz F, Casillas M, García Lax F, Alix Trueba A, Rivas C. Trasplantes experimentales de pulmón. Rev Clin Esp. 1963;87:163-7.
2. Borro JM, Ramos F, Vicente R, Sanchis F, Morales P, Cafarena JM. Bronchial fistula to the mediastinum in a heart-lung transplant patient. Eur J Cardiothorac Surg. 1992;6:674-6.
3. Roman A, Morell F, Astudillo J, Margarit C, Bravo C, Tenorio L, et al, y Grupo de Trasplante Pulmonar del HVH. Trasplante unipulmonar: los dos primeros casos. Med Clin (Bare). 1993; 100:380-3.
4. Astudillo J, Bravo C, Margarit C, Guillermo MI, Tenorio L, y Grupo de Trasplante Pulmonar. Trasplante bipulmonar secuencial. Técnica y resultados de los tres primeras casos. Arch Bronconeumol. 1994;30:348-53.
5. Borro JM, Calvo V, Morales P, Morant P, Sales G, Ferrer J. El trasplante pulmonar en la fibrosis quistica. An Esp Pediatr. 1996;45:505-10.
6. Borro JM, Morales P, Lozano C, Tarrazona V, Morant P, Galán G, et al. 1990-1996, experiencia del Grupo de Trasplante Pulmonar de La Fe-Valencia. Arch Bronconeumol. 1997;33:438-43.
7. Lazaro MT, Ussetti P, Ferreiro MJ, Carreno MC, Pablo A, Garcia F, et al. Supervivencia del trasplante pulmonar en la Clinica Puerta de Hierro. Arch Bronconeumol. 1998;34:285-8.
8. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Kerck BM, Hertz MI. The registry of the International Society for Heart and Lung Transplantation: twenty-first oficial adult lung and heart-lung transplant report-2004. J Heart Lung Transplant. 2004; 23:804-15.
9. Borro JM, De la Torre M, Bonome C, Otero I, Miguelez C, Refojo F, et al. Segunda generación de grupos de trasplante pulmonar: experiencia inicial de la comunidad gallega. Arch Bronconeumol. 2000;36 Supl 2:39.
10. Yu AD, Garrity ER. Recipient selection. Chest Surg Clin N Am. 2003;13:405-28.
11. Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J. 2003;22:845-52.
12. De Pablo A, Morales P, Roman A, Lama R, García López F, Borro JM, et al. EPOC y trasplante pulmonar: resultados en España. Arch Bronconeumol. 1999;35:334-8.
13. Borro JM, Calvo V, Morales P, Morant P, Morcillo A, Tarazona V. Clinical experience on lung transplantation for treatment of cystic fibrosis advance stage. Trasplantology. 1998;3:63-6.
14. Lázaro-Carrasco MT, Morales P, Ferreiro MJ, Borro JM, Varela A, Vicente R, et al. Trasplante pulmonar en Ia fibrosis quística. Rev Clin Esp. 1999;199:280-4.
15. Magulkoc M, Brutsche MH, Bishop PW, Greaves M, Horrocks A, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001;164:103-8.
16. Gaudo J, Pacheco A, Máiz L. Actualización de criterios para trasplante pulmonar en la fibrosis pulmonar idiopática. Arch Bronconeumol. 2002;38:251-2.
17. Higenbottam T, Butt AY, McMahon A, Westerbeck R, Sharples L. Long term intravenous prostaglandin for treatment of severe pulmonary hypertension. Heart. 1998;80:151-5.
18. Sitbon O, Humbert M, Nunes H, Parent F, García G, Herve P, et al. Long term intravenous epoprostenol infusion in primary pulmonary hypertension. J Am Coll Cardiol. 2002;40:780-8.
19. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-9.
20. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896-903.
21. Rothman A, Sklansky MS, Lucas VW, Kazan IA, Shaughnessy RD, Channick RN, et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol. 1999;84:682-6.
22. Prados C, Máiz L, Antelo C, Baranda F, Blázquez J, Borro JM, et al. Fibrosis quística: consenso sobre el tratamiento del neumotórax y de la hemoptisis masiva y sobre las indicaciones del trasplante pulmonar. Arch Bronconeumol. 2000;36:411-6.
23. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. Transplantation. 1998;66:951-6.
24. Grupo de trabajo de la SEPAR. Normativa SEPAR. Trasplante pulmonar. Arch Bronconeumol. 2001;37:307-15.
25. Álvarez A, Lama R, Algar J, Santos F, Briceño J, Aranda JL, et al. Predicting mortality after lung transplantation. Trasplant Proc. 2001;33:1630-1.
26. Zorn GL Jr, McGiffin DC, Young KR Jr, Alexander CB, Weill D, Kirklin JK. Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 2003;125:20-2.
27. Morales P, Hernández D, Vicente R, Solé A, Moreno I, Torres JJ, et al. Lung transplantation in patients with x-linked agammaglobulinemia. Transplant Proc. 2003;35:1942-3.
28. Shargall Y, Pakhale S, Chamberlain D, Pierre A, Waddeil T, Hutcheon M, et al. Bilateral lung transplantation for metastatic leiomyosarcoma. J Heart Lung Transplant. 2004;23:912-5.
29. Algar FJ, Álvarez A, Lama R, Santos A, Aranda JL, Baamonde C, et al. Lung transplantation in patients under mechanical ventilation. Transplant Proc. 2003;35:737-8.
30. Calvo V, Padilla J, García-Zarza A, Blasco E, Pastor J, Paris F. El trasplante pulmonar en situacion de urgencia. Arch Bronconeumol. 2003;39:111-4.
31. Miranda B, Matesanz R, Fernández Lucas M, Naya MT, Felipe. C. Organ donation in Spain: evolution of organ donor characteristics. Transplantation Proc. 1996;28:175-6.
32. Ciccone AM, Meyers BF, Guthrie TJ, Battafarano RJ, Trulock EP, Cooper JD, et al. Does donor cause of death affect the outcome of lung transplantation. J Thorac Cardiovasc Surg. 2002; 123:429-36.
33. Aigner C, Seebacher G, Kepletko W. Donor selection. Chest Surg Clin N Am. 2003;13:429-42.
34. Álvarez A, Algar FJ, Santos F, Lama R, Baamonde C, Aranda JL, et al. The donor lung assessment: experience of the Reina Sofía Hospital. Transplant Proc. 2003;35:739-41.
35. Sunderesan S, Semenkovich J, Ochoa L. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995;109:1075-80.
36. Padilla J, Calvo V, Teixidor J, Varela A, Carbajo M, Álvarez A. Pulmonary "twinning" transplantation procedure. Transplant Proc. 2002;34:1287-9.
37. Meyers BF, Lynch J, Trulock EP, Gutric TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg. 1999;230:362-70.
38. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lung from a non heart-beating donor. Lancet. 2001;357:825-9.
39. Núñez JR, Varela A, Del Río F, Gámez P, Calatayud J, Córdoba M, et al. Bipulmonary transplants with lungs obtained from two non-heart-beating donors who died out of hospital. J Thoracic Cardiovasc Surg. 2004;127:297-9.
40. Starnes VA, Bowdish ME, Woo MS, Barbers RG, Schenkel FA, Horn MV, et al. A decade of living lobar lung transplantation: recipient outcomes. J Thorac Cardiovasc Surg. 2004;127:114-22.
41. Couetil JA, Tolan MJ, Loulmet DF. Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg. 1997;113:529-37.
42. Perrot M, Keshavjee S. Lung preservation. Chest Surg Clin N Am. 2003;13:433-62.
43. Padilla AM, Padilla JD. Estado actual de la preservación pulmonar. Arch Bronconeumol. 2004;40:86-93.
44. Keshavjee SH, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg. 1989;98:529-34.
45. Date H, Matsumura A, Manchester JK, Obo H, Lima O, Cooper JM, et al. Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. J Thorac Cardiovasc Surg. 1993;105:480-91.
46. Struber M, Hohlfeld JM, Fraund S, Kim P, Warnecke G, Haverich A. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg. 2000;120:566-72.
47. Rabanal JM, Ibáñez AM, Mons R, González AM, Carbajo M, Ortega J, et al. Influence of preservation solution on early lung function. Transplant Proc. 2003;35:1938-9.
48. Sarsam MA, Donan NA, Deiranika AK, Rahman AN. Retrograde pulmonary plegia for lung preservation in clinical transplantation: a new technique. J Heart Lung Transplant. 1993;12:494-8.
49. Varela A, Montera CG, Cordoba M, Antequera A, Pérez M, Tabuenca MJ, et al. Improved distribution of pulmonary flush solution to the tracheobronchial wall in pulmonary transplantation. Eur Surg Res. 1997;29:1-4.
50. Varela A, Montera C, Córdoba M, Serrano-Fiz S, Burgos R, Téllez JC, et al. Clinical experience with retrograde lung preservation. Transp Int. 1996;9:S296-S8.
51. Venuta F, Rendina EA, Bufi M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovas Surg. 1999;118:107-14.
52. Varela A, Córdoba M, Serrano-Fiz S, Burgos R, Montera C, Téllez JC, et al. Early lung allograft function after retrograde and anterograde preservation. J Thorac Cardiovasc Surg. 1997;114:1119-20.
53. Álvarez A, Salvatierra A, Lama R, Algar J, Cerezo F, Santos F. Preservation with a retrograde second flushing of Eurocollins in clinical lung transplantation. Transplant Proc. 1999;31:1088-90.
54. Borro JM, Tarrazona V, Galán G, Calvo V, Lozano C, Morant P, et al, y Grupo de Trasplante Pulmonar de La Fe. Ampliando indicaciones en el trasplante bipulmonar secuencial. Arch Bronconeumol. 1999;35:129-35.
55. Cassivi SD, Meyers BF, Battafarano RJ. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg. 2002;74:1663-9.
56. McAdams HP, Erasmus JJ, Palmer SM. Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance. Radiology. 2001;218:233-41.
57. Venuta F, Boehler A, Rendina EA, De Giacomo T, Speich R, Schmid R. Complications in the native lung after single lung transplantation. Eur J Cardiothorac Surg. 1999;16:54-8.
58. Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant. 1999;18:1080-7.
59. Khaghani A, Al-Kattan KM, Tadjkarimi S, Banner N, Yacoub M. Early experience with single lung transplantation for emphysema with simultaneous volume reduction of the contralateral lung. Eur J Cardiothorac Surg. 1997;11:604-8.
60. Estenne M, Cassart M, Poncelet P, Gevenois PA. Volume of graft and native lung after single-lung transplantation for emphysema. Am J Respir Crit Care Med. 1999;159:641-5.
61. Yonan NA, El-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya AK. Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant. 1998;17:192-201.
62. Anderson MB, Kriett JM, Kapelanski DP, Perricone A, Smith CM, Jamieson SW. Volume reduction surgery in the native lung after single lung transplantation for emphysema. J Heart Lung Transplant. 1997;16:752-7.
63. Mitchell JB, Shaw AD, Donald S, Farrimond JG. Differential lung ventilation after single-lung transplantation for emphysema. J Cardiothorac Vase Anesth. 2002;16:459-62.
64. Lau CL, Patterson GA. Current status of lung transplantation. Eur Respir J. 2003;22:57S-64S.
65. Morales P, Almenar L, Torres JJ, Sole A, Vicente R, Ramos F, et al. Cardiopulmonary transplantation: experience of a lung transplant group. Transplant Proc. 2003;35:1954-6.
66. Veith FJ, Montefusco C, Kamlolz SL, Mollenkopf FP. Lung transplantation. Heart Trasplant. 1983;2:155-6.
67. Pearson FG. Lung transplantation: the Toronto experience. Eur J Cardiothorac Surg. 1989;3:6-11.
68. Cooper JD, Pearson FG, Patterson GA, Todd TRJ, Ginsberg RJ, Goldgerg M, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93:173-81.
69. Patterson GA, Cooper JD, Goldman B, Weisel RD, Pearson FG, Waters PF, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg. 1988;45:626-33.
70. Lau CL, Paterson GA. Technical consideration in lung transplantation. Chest Surg Clin N Am. 2003;13:463-83.
71. Meyers, BK, Sundaresan RS, Guthrie T, Cooper JD, Patterson GA. Bilateral sequential lung transplantation without sternal division eliminates potransplantation sternal complications. J Thorac Cardiovascular Surg. 1998;117:358-64.
72. Varela A, Montera C, Castedo E, Roda J, Gámez P, Madrigal L, et al. Transcutaneous extracorporeal cannulation for bilateral lung transplantation without splitting the sternum. J Torac Cardiovasc Surg. 2000;119:402-3.
73. Gómez FJ, Planas A, Ussetti P, Tejada JJ, Varela A. Factures pronosticos de morbimortalidad temprana en el trasplante pulmonar. Arch Bronconeumol. 2003;39:353-60.
74. Nelly RF. Current strategies in lung preservation. J Lab Clin Med. 2000;136:427-40.
75. Rabanal J, Mons R, Zurbano F, Ruiz I, Alcíbar J, Ortega J. Edema postimplante en el trasplante pulmonar. Isquemia-reperfusión o edema hidrostático. Rev Esp Anestesiol Reanim. 2001;48:146-50.
76. Thabut G, Vinatier I, Brugière O, Lesèche G, Loirat P, Bisson A, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med. 2001; 164:1204-8.
77. Strüber M, Wihlemi M, Harringer W, Niedemeyer J, Anssar M, Kunseberck A, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg. 2001;19:190-4.
78. Fischer S, Matte-Martyn A, De Parrot M, Waddell T, Sekine Y, Hutcheon M, et al. Low-potassium dextran preservation solution improves lung function alter lung transplantation. J Thorac Cardiovasc Surg. 2001;120:594-6.
79. Salvatierra A, Guerrero R, Rodríguez M, Álvarez A, Soriano F, López-Pedrera R, et al. Antitrombin III prevents early pulmonary dysfunction alter lung transplantation in the dog. Circulation. 2001;11:2975-80.
80. Couraud L, Nashef SAM, Nicolini P, Jougon J. Classification of airway anastomotic healing. Eur J Cardiothorac Surg. 1992;6: 496-7.
81. Álvarez A, Algar A, Santos F, Lama R, Aranda JL, Baamonde C, et al. Airway complications alter lung transplantation: a review of 151 anastomoses. Eur J Cardiothorac Surg. 2001;19:381-7.
82. Hasegawa T, Iacono AT, Orons PD, Yousem SA. Segmental non-anastomotic bronchial stenosis after lung transplantation. Ann Thoracic Surg. 2000;69:1020-4.
83. Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, et al. Prospective analysis of 1235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant. 2002;21:1062-7.
84. Chakinala MM, Trulock EP. Acute allograft rejection after lung transplantation: diagnosis and therapy. Chest Surg Clin N Am. 2003;13:525-42.
85. Hasegawa T, Iacono AT, Yousem SA. The anatomic distribution of acute cellular rejection in the allograft lung. Ann Thorac Surg. 2000;69:1529-31.
86. Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, et al. Revision of 1990 Working Formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant. 1996;15:1-15.
87. Slebos D, Postma DS, Koëter GH, Van der Bij W, Boezen M, Kauffman HF. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection. J Heart Lung Transplant. 2004;23:532-40.
88. Studer SM, Orens JB, Rosas I, Krishnan JA, Cope KA, Yang S, et al. Patterns and significance of exhaled biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant. 2001;20:1158-66.
89. Valentine VG, Taylor DE, Dhillon GS, Knower MT, McFadden PM, Fuchs DM, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant. 2002;21: 319-26.
90. Baz MA, Layish DT, Covert JA, Howell DN, Lawrence CM, Davis RD, et al. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest. 1996;110:84-8.
91. Sharples LD, McNei K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant. 2002;21:271-81.
92. Heng D, Sharples LD, McNeil K. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant. 1998;17:1255-63.
93. Lama R, Santos F, Algar FJ, Álvarez A, Baamonde C. Lung transplants with tacrolimus and mycophenolate mofetil: a review. Transplant Proc. 2003;35:1968-73.
94. Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart, et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as immunossuppresion after lung transplantation. J Thoracic Cardiovasc Surgery. 2003;125:891-900.
95. Zuckerman A, Klepetko W, Birsan T, et al. Comparison between mycophenolate mofetil and azathioprine-based immunosuppressions in clinical lung transplantation. J Heart Lung Transplant. 1999; 18:432-40.
96. Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF. Rabbit antithymocyte globulin decrease acute rejection after lung transplantation: result of a randomized, prospective study. Chest. 1999;116:127-33.
97. Garrity ER, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001;71:773-7.
98. Brock MV, Borja MC, Ferber L, Orens JB, Anzcek RA, Krishnan J, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte antibody and daclizumab. J Heart Lung Transplant. 2001;20: 1282-90.
99. Iacono AT, Johnson BA, Corcoran T, Smith DA, Grgurich WF, Dauber JH, et al. A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients. J Heart Lung Transplant. 2004;23:S175.
100. Carreño MC, Ussetti P, Varela A, Mendaza P, Daza R, Ferreiro MJ, et al. Infeccion en el trasplante pulmonar. Arch Bronconeumol. 1996;32:442-6.
101. Borro JM, Vicente R, Tarazona V, Paris F, Gobernado M. Aproximación a la infección bacteriana en el trasplante pulmonar. Rev Clin Esp. 1995;195:22-6.
102. Aris RM, Routh JC, Li Puma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Am J Respir Crit Care Med. 2001;164:2102-6.
103. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patines with cystic fibrosis. Lancet. 2001;358:1780-1.
104. Glanville AR, Valentine VG, Aboyoun CL, Malouf MA. CMV mismatch is not a risk factor for survival or severe bronchiolitis obliterans syndrome alter lung transplantation. J Heart Lung Transplant. 2004;23:S43.
105. Kruger RM, Paranjothi S, Storch GA, Lynch JP, Trulock EP. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients. J Heart Lung Transplant. 2003;22:754-63.
106. Monforte V, Roman A, Gavaldá J, López R, Pou L, Simó M, et al. Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation. 2003;75:1571-4.
107. Monforte V, Román A, Gavaldá J, Bravo C, Tenorio L, Ferrer A, et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant. 2001;20:1274-81.
108. Calvo V, Borro JM, Tarazona V, Morcillo A, Paris F. Antifungal prophylaxis in early postoperative period in lung transplantation. Chest. 1999;115:1301-4.
109. Ferrer J, Roldán J, Román A, Bravo C, Monforte V, et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant. 2003;22:1217-25.
110. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Trasplant. 1993; 12:713-6.
111. Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297-310.
112. Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17:363-8.
113. Hartwig MG, Cantu E, Appel JZ, Woreta H, Palmer SM, Davis RD. Non alloimmune injury mediated by gastroesophageal reflux precipitates alloimmune injury in lung transplant patients. J Heart Lung Transplant. 2004;23:S43.
114. Fisher AJ, Gabbay E, Small T, Doig S, Dark JH, Corns PA. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax. 1998;53:454-8.
115. Verleden GM, Delacroix M, Buyse B, Dupont L, Leuven Lung Transplant Group. Exhaled NO after lung transplantation; a prospective study. J Heart Lung Transplant. 2001;20:208.
116. Corris PA. Bronchiolitis obliterans syndrome. Chest Surg Clin N Am. 2003;13:543-57.
117. Lama R, Alvarez A, Santos F, Algar J, Aranda JL, Baamonde C, et al. Long-term result of lung transplantation for cystic fibrosis. Transplant Proc. 2001;33:1624-5.
118. Álvarez A, Lama R, Algar J, Santos F, Briceno J, Aranda JL, et al. Predicting mortality after lung transplantation. Transplant Proc. 2001;33:1630-1.
119. Limbos MM, Joyce DP, Chan CK, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest. 2000;118:408-16.
120. Ten Vergertert EM, Vermeulen KM, Geertsma A, et al. Quality of life before and after lung transplantation in patients with emphysema versus other indications. Psychol Rep. 2001;89:707-17.